Keytruda 100 MG/4 ML vial 4ML
Ended Awarded Last action
- Contract number
- SPE2DR26FSCC1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $102,470
Award facts
- Contract value 100% obligated
- $102,470.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $102,470.44 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Keytruda 100 mg/4 ml vials. The award, issued on December 19, 2025, with an ultimate completion date of January 13, 2026, utilizes firm fixed-price pricing with no set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which carries a $499,999,999 ceiling and extends through December 31, 2036.
The PPV-G GEN V represents a strategic $30.3 billion acquisition initiative designed to consolidate pharmaceutical supply chains across the Department of Defense's global military healthcare operations. DMS Pharmaceutical Group's role as a regional prime vendor contractor enables the agency to issue firm fixed-price delivery orders for an extensive portfolio of branded and generic prescription medications, biologics, vaccines, and medical consumables. The company's demonstrated performance across numerous delivery orders, coupled with its established presence in the federal pharmaceutical supply chain since 2001, positions it as a critical supplier for recurring medical supply requirements of military healthcare facilities worldwide.
Quick answers
Who was awarded contract SPE2DR26FSCC1?
SPE2DR26FSCC1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 19, 2025.
How much is contract SPE2DR26FSCC1 worth?
The government has obligated $102,470 on SPE2DR26FSCC1.
Is contract SPE2DR26FSCC1 an order under another contract?
Yes. SPE2DR26FSCC1 is a delivery order under SPE2DR25D9316, an indefinite delivery contract.
Was contract SPE2DR26FSCC1 competed?
The extent of competition for SPE2DR26FSCC1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award